|
GB935962A
(en)
|
1960-06-17 |
1963-09-04 |
Fujisawa Pharmaceutical Co |
Improvements in or relating to the production of 6.8-dithiooctanamides
|
|
US3855240A
(en)
|
1969-04-28 |
1974-12-17 |
Exxon Research Engineering Co |
Sulfur containing heterocycles
|
|
US4210667A
(en)
|
1979-04-19 |
1980-07-01 |
Pfizer Inc. |
Pharmaceutical preparations containing coumarin carboxylic acid derivatives
|
|
US4755528A
(en)
|
1984-12-06 |
1988-07-05 |
Alcon Laboratories, Inc. |
High energy ionizing protective 2,3-diamino-1,4-butanedithiol; 4,5-diamino-1,2-dithiane; and N-acyl and N-alkyl derivatives thereof, compositions and method of use therefor
|
|
US6030950A
(en)
|
1987-07-09 |
2000-02-29 |
Ohlenschlaeger; Gerhard |
Pharmaceutical therapeutic use of glutathione derivative
|
|
US5599903A
(en)
|
1992-04-03 |
1997-02-04 |
Terrapin Technologies, Inc. |
Glutathione analogs and paralog panels comprising glutathione mimics
|
|
FR2638970A1
(fr)
|
1988-11-16 |
1990-05-18 |
Corbiere Jerome |
Nouvelles compositions pharmaceutiques agissant sur la presbytie et leur procede d'obtention
|
|
WO1993002639A1
(en)
|
1991-08-06 |
1993-02-18 |
Autogenesis Technologies, Inc. |
Injectable collagen-based compositions for making intraocular lens
|
|
US5466680A
(en)
|
1992-03-26 |
1995-11-14 |
Cytologics, Inc. |
Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface
|
|
US5459133A
(en)
|
1992-06-05 |
1995-10-17 |
Telor Ophthalmic Pharmaceuticals, Inc. |
Methods and products for treating presbyopia
|
|
AU4633793A
(en)
|
1992-06-10 |
1994-01-04 |
Summit Technology, Inc. |
Correction of presbyopia by photorefractive keratectomy
|
|
WO1994001096A1
(en)
|
1992-07-02 |
1994-01-20 |
Telor Ophthalmic Pharmaceuticals, Inc. |
Methods and products for treating presbyopia
|
|
JPH08505119A
(ja)
|
1992-07-06 |
1996-06-04 |
バイオミラ、インコーポレーテッド |
接合目的のためのタンパク質の光活性化
|
|
US5354331A
(en)
|
1992-07-15 |
1994-10-11 |
Schachar Ronald A |
Treatment of presbyopia and other eye disorders
|
|
US5465737A
(en)
|
1992-07-15 |
1995-11-14 |
Schachar; Ronald A. |
Treatment of presbyopia and other eye disorders
|
|
DK0653926T3
(da)
|
1992-08-07 |
1999-11-01 |
Keravision Inc |
Intrastromal cornealring
|
|
DE4345199C2
(de)
|
1993-05-22 |
1995-10-12 |
Asta Medica Ag |
Verwendung von Dihydroliponsäure zur Unterdrückung von Unverträglichkeitsreaktionen im Grenzbereich von Implantaten mit lebendem Körpergewebe
|
|
US5395356A
(en)
|
1993-06-04 |
1995-03-07 |
Summit Technology, Inc. |
Correction of presbyopia by photorefractive keratectomy
|
|
US5527774A
(en)
|
1993-07-12 |
1996-06-18 |
Girard; Louis J. |
Dislocation of cataractous lens by enzymatic zonulolysis
|
|
US5665770A
(en)
|
1993-11-05 |
1997-09-09 |
Gakko Hojin Kinki Daigaku |
Method for treatment of cataract with radical scavenger
|
|
EP0754046A1
(en)
|
1994-04-04 |
1997-01-22 |
FREEMAN, William R. |
Use of phosphonylmethoxyalkyl nucleosides for the treatment of raised intraocular pressure
|
|
US6063116A
(en)
|
1994-10-26 |
2000-05-16 |
Medarex, Inc. |
Modulation of cell proliferation and wound healing
|
|
US6743779B1
(en)
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
|
US5624955A
(en)
|
1995-05-03 |
1997-04-29 |
Regents Of The University Of Minnesota |
Compounds that enhance the concentration of glutathione in tissues
|
|
US5686450A
(en)
|
1995-06-07 |
1997-11-11 |
Alcon Laboratories, Inc. |
Use of N,N'-bis(mercaptoacetyl) hydrazine derivatives as anticataract agents
|
|
US6007510A
(en)
|
1996-10-25 |
1999-12-28 |
Anamed, Inc. |
Implantable devices and methods for controlling the flow of fluids within the body
|
|
US5817630A
(en)
|
1997-03-18 |
1998-10-06 |
Austin Nutriceutical Corporation |
Glutathione antioxidant eye drops
|
|
AU728488B2
(en)
|
1997-04-02 |
2001-01-11 |
Sankyo Company Limited |
Dithiolan derivatives, their preparation and their therapeutic effect
|
|
US5843184A
(en)
|
1998-01-26 |
1998-12-01 |
Cionni; Robert J. |
Endocapsular tension ring and method of implanting same
|
|
US6153647A
(en)
|
1998-11-12 |
2000-11-28 |
My-Tech, Inc. |
Method for augmenting the inotropic effects of β-adrenergic agonists using pyruvate therapy
|
|
US6472541B2
(en)
|
1998-11-20 |
2002-10-29 |
The Regents Of The University Of California |
Protecting groups with increased photosensitivities
|
|
AU758903B2
(en)
|
1998-11-26 |
2003-04-03 |
Pentapharm Ag |
Transport system conjugate
|
|
US6288106B1
(en)
|
1999-05-25 |
2001-09-11 |
Chronorx, Llc |
Processes for the synthesis and use of various α-lipoic acid complexes
|
|
US6339102B1
(en)
|
1999-06-09 |
2002-01-15 |
The United States Of America As Represented By The Secretary Of The Army |
Method and composition for treating and preventing retinal damage
|
|
JP4476435B2
(ja)
*
|
1999-07-22 |
2010-06-09 |
株式会社細川洋行 |
仕切部材、複室輸液容器および薬剤入り複室輸液容器の製造方法
|
|
US6890896B1
(en)
|
1999-11-18 |
2005-05-10 |
Ceremedix, Inc. |
Compositions and methods for counteracting effects of reactive oxygen species and free radicals
|
|
US6387945B2
(en)
|
2000-04-11 |
2002-05-14 |
The Regents Of The University Of California |
Lipoic acid analogs
|
|
JP2004502484A
(ja)
|
2000-07-10 |
2004-01-29 |
コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ |
撮像医用装置に対する幾何学適合
|
|
US6906210B2
(en)
|
2000-08-02 |
2005-06-14 |
Basf Aktiengesellschaft |
Method for producing lipoic acid and dihydrolipoic acid
|
|
US20050112113A1
(en)
|
2000-08-16 |
2005-05-26 |
Till Jonathan S. |
Presbyopia treatment by lens alteration
|
|
US8697109B2
(en)
|
2000-08-16 |
2014-04-15 |
Encore Health, Llc |
Caged mercaptan and seleno-mercaptan compounds and methods of using them
|
|
US8147816B2
(en)
|
2000-08-16 |
2012-04-03 |
Encore Health, Llc |
Presbyopia treatment by lens alteration
|
|
US7935332B2
(en)
|
2000-08-16 |
2011-05-03 |
Encore Health, Llc |
Presbyopia treatment by lens alteration
|
|
US6923955B2
(en)
|
2000-08-16 |
2005-08-02 |
Newlens, Llc |
Presbyopia treatment by lens alteration
|
|
AU2001283386A1
(en)
|
2000-08-16 |
2002-02-25 |
Refocus, Llc. |
Presbyopia treatment by lens alteration
|
|
US7914815B2
(en)
|
2000-08-16 |
2011-03-29 |
Encore Health, Llc |
Method for delivery of pharmaceuticals for treating or preventing presbyopia
|
|
US8647612B2
(en)
|
2008-03-05 |
2014-02-11 |
Encore Health, Llc |
Dithiol compounds, derivatives, and treatment of presbyopia
|
|
DE10045059A1
(de)
|
2000-09-12 |
2002-03-21 |
Basf Ag |
Therapeutische Kombination von Liponsäure und Konjuensäuren zur Behandlung diabetischer Störungen
|
|
US6273092B1
(en)
|
2000-09-22 |
2001-08-14 |
Gerard M. Nolan |
Methods for treating various eye disorders
|
|
US6703039B2
(en)
|
2000-12-06 |
2004-03-09 |
Bausch & Lomb Incorporated |
Reversible gelling system for ocular drug delivery
|
|
EP1808158A3
(en)
|
2001-01-19 |
2008-06-18 |
Newlens, LLC |
Presbyopia treatment by lens alteration
|
|
JP4072062B2
(ja)
|
2001-03-19 |
2008-04-02 |
千寿製薬株式会社 |
新規α−リポ酸誘導体およびその用途
|
|
JP2005515156A
(ja)
|
2001-05-25 |
2005-05-26 |
セレメディックス，インク． |
反応性酸素種およびフリーラジカルの効力を中和するための単一アミノ酸に基づく化合物
|
|
FR2832637B1
(fr)
|
2001-06-07 |
2004-07-30 |
Lefaix Marie Therese Droy |
Utilisation d'un antioxydant pour la fabrication d'un medicament destine au traitement des affections oculaires de surface
|
|
ITMI20011232A1
(it)
|
2001-06-12 |
2002-12-12 |
St Microelectronics Srl |
Metodo di riprogrammazione successiva ad una operazione di cancellazione di una matrice di celle di memoria non volatile, in particolare di
|
|
WO2003084532A1
(en)
|
2002-04-03 |
2003-10-16 |
Avery Mitchell A |
Lipoic acid analogs useful as provitamins and antioxidants
|
|
US20050137124A1
(en)
|
2002-08-09 |
2005-06-23 |
Vitreo-Retinal Technologies, Inc. A California Corporation |
Agents for intravitreal administration to treat or prevent disorders of the eye
|
|
WO2004024139A1
(ja)
|
2002-09-13 |
2004-03-25 |
Oga Research, Incorporated |
メラニン消去剤
|
|
US7795203B2
(en)
*
|
2002-09-30 |
2010-09-14 |
Babizhayev Mark A |
Method for topical treatment of eye disease and composition and device for said treatment
|
|
US20060177430A1
(en)
|
2002-12-20 |
2006-08-10 |
Chakshu Research Inc |
Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer
|
|
US7941211B2
(en)
|
2003-11-17 |
2011-05-10 |
Zeavision, Llc. |
Preloading with macular pigment to improve photodynamic treatment of retinal vascular disorders
|
|
WO2005051978A2
(en)
|
2003-11-25 |
2005-06-09 |
University Of Rochester |
Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof
|
|
US7718697B2
(en)
|
2003-12-17 |
2010-05-18 |
Alcon, Inc. |
Method for treating glaucoma comprising administering α-lipoic acid
|
|
GB0404693D0
(en)
|
2004-03-02 |
2004-04-07 |
Univ London |
Pharmaceutical preparations for the treatment of ocular surface and other disorders
|
|
FR2869531B1
(fr)
|
2004-04-30 |
2006-07-14 |
Optis France Sa Sa |
Dispositif de iontophorese oculaire diminuant les irritations
|
|
US7264279B2
(en)
|
2004-07-08 |
2007-09-04 |
Fab-Tech, Inc. |
Segmented conduit having a monolithic lining
|
|
US20080038316A1
(en)
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
|
US20060188492A1
(en)
|
2005-01-13 |
2006-08-24 |
Chronorx Llc, An Alaska Limited Liability Company |
Topical management of ocular and periocular conditions
|
|
US20060275278A1
(en)
*
|
2005-06-02 |
2006-12-07 |
Choy Camus K M |
Method and ophthalmic formulation for eye protection or treatment
|
|
CA2615360A1
(en)
|
2005-07-15 |
2007-01-25 |
Chakshu Research Inc. |
Formulation and method for administration of ophthalmologically active agents
|
|
US20070055070A1
(en)
|
2005-09-07 |
2007-03-08 |
Lawrence Lowell J |
Novel esters of lipoic acid
|
|
US20070207116A1
(en)
*
|
2006-03-01 |
2007-09-06 |
Brown David C |
Antioxidant compositions for the eye
|
|
CN101522658A
(zh)
|
2006-06-16 |
2009-09-02 |
因迪基恩药物公司 |
作为抗糖尿病药用于控制糖尿病高血糖症和糖尿病并发症的二甲双胍r-(+)硫辛酸盐
|
|
BRPI0720000A2
(pt)
*
|
2006-12-08 |
2013-12-17 |
Sachtleben Chemie Gmbh |
Corpo moldado contendo titâno
|
|
DE102006062599B4
(de)
|
2006-12-29 |
2018-03-08 |
Endress + Hauser Gmbh + Co. Kg |
Opto-elektronische Vorrichtung zur Übertragung eines elektrischen Signals und deren Verwendung
|
|
EP2131679B1
(en)
|
2007-02-22 |
2019-03-27 |
Children's Hospital & Research Center at Oakland |
Fatty acid formulations and methods of use thereof
|
|
JP2010520333A
(ja)
|
2007-03-01 |
2010-06-10 |
セダーズ−シナイ メディカル センター |
〔１，２〕−ジチオラン部分を含有する抗酸化剤重合体およびその使用
|
|
UA86441C2
(ru)
|
2007-03-30 |
2009-04-27 |
Акционерное Общество Открытого Типа "Галичфарм" |
(2-гидроксиэтил)триметиламмония тиоктат (холина тиоктат), имеющий гепатопротекторное, гипоаммониемическое и детоксицирующее действие, способ его получения, фармацевтическая композиция на его основе
|
|
KR20100045503A
(ko)
*
|
2007-08-09 |
2010-05-03 |
센주 세이야꾸 가부시키가이샤 |
피레녹신 함유 2 액성 점안제
|
|
US9044439B2
(en)
*
|
2008-03-05 |
2015-06-02 |
Encore Health, Llc |
Low dose lipoic and pharmaceutical compositions and methods
|
|
WO2009111635A2
(en)
|
2008-03-05 |
2009-09-11 |
Encore Health, Llc |
Dithiol compounds, derivatives, and uses therefor
|
|
WO2010147962A1
(en)
*
|
2009-06-15 |
2010-12-23 |
Encore Health, Llc |
Choline esters
|
|
EP2442647B1
(en)
|
2009-06-15 |
2016-03-16 |
Encore Health LLC |
Dithiol compounds, derivatives, and uses therefor
|
|
DE102010009475B4
(de)
*
|
2010-02-26 |
2011-11-24 |
F. Holzer Gmbh |
Verfahren zur Herstellung eines dosierbaren applikationsfertigen Präparates
|
|
ES2564502T3
(es)
|
2010-03-17 |
2016-03-23 |
Novaliq Gmbh |
Composición farmacéutica para el tratamiento de la presión intraocular aumentada
|
|
AU2012204932B2
(en)
*
|
2011-01-04 |
2017-02-23 |
Novaliq Gmbh |
O/w-emulsions comprising semifluorinated alkanes
|
|
CN104066442B
(zh)
*
|
2012-01-23 |
2018-05-18 |
诺瓦利克有限责任公司 |
基于半氟化烷烃的稳定蛋白质组合物
|
|
EP3479839A1
(en)
*
|
2012-02-22 |
2019-05-08 |
Stealth Peptides International, Inc. |
Methods and compositions for preventing or treating opthalmic conditions
|